Case Comprehensive Cancer Center

With a new five-year, $2.78 million grant from the National Institutes of Health and National Cancer Institute, researchers at Case Western Reserve University (CWRU), Cleveland Clinic and University Hospitals (UH) will use artificial intelligence (AI) to better treat rectal cancer patients. The…

Nathan Berger with his wife, Sosamma J. Berger Nathan Berger arrived in Cleveland in 1983 with a vision: creating an oncology/hematology training program to position Case Western Reserve University School of Medicine as a leader in the burgeoning field of cancer care. The program he…

Eduarda Grinsztejn, MD, Case CCC Trainee Associate member, is one of nine individuals selected by the American Society of Hematology (ASH) for its 2024 ASH Minority Hematology Fellow Award (MHFA). This award encourages early-career researchers from historically underrepresented groups in the United…

An inter-organizational group of researchers and administrators from Case CCC recently published their work, "Impact of clinical trial design on recruitment of racial and ethnic minorities," in the Journal of Cancer Education. Case CCC affiliates include Population and Cancer Prevention Program…

The inaugural class of physician-scientists gathered with Case CCC leadership to celebrate the start of the Emerging Leaders Program (ELP)—an initiative aimed at developing leaders to take Case CCC to and beyond the half-century mark. The highly competitive selection process identified 10…

Neekkan Dey, a postdoc in the Department of Biochemistry, wrote an article accepted for publication in Molecular Cancer Research Journal by American Association for Cancer Research (AACR). Dey works in J. Alan Diehl’s group based at the Case Comprehensive Cancer Center. Dey’s study, titled…

Presentations, collegial debates, networking, and a spirit of collaboration were the themes throughout the evening at the 2024 Cleveland Gastrointestinal (GI) Oncology Consortium Meeting planned jointly by cancer experts from University Hospitals (UH) and Cleveland Clinic (CCF) with support from…

Co-leaders of Case CCC's Cancer Imaging Program, Agata Exner, PhD (PI) and James Basilion, PhD (MPI) received a four-year, $2.4M NIH grant to continue the development, implementation, and clinical translation of the first prostate cancer cell-targeted ultrasound contrast agent. The research team…

Funding supports newly published findings showing some medications trigger ‘cell blasters’ to kill cancer

Nearly 200 people attended Case CCC's Second Annual Microbiome Workshop Feb. 7-8, 2024. The two-day event focused on the latest developments in microbiome cancer research and covered topics such as microbiome and immunity, metabolism and the microbiome, therapeutic implications of microbiome…